MedaSync

Cleveland, OH · Founded 2016 · Privately Held (backing)

Developer of a reimbursement software designed to automate and streamline the operations of skilled nursing operators. MedaSync is based in Cleveland, OH and was founded in 2016. It was valued at $11.2 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $3.6 million across 2 recorded rounds; the latest was a $1.6 million seed round in Feb 2024.

PMV mark · valuation
$11.2M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$3.6M
Last round
Seed Round
Feb 2024
What is MedaSync worth?
$11.2MPrivateMarketView mark · Oct 2026

Valued at $11.2M at its later-stage round, Aug 2025. Nothing has traded since.

Free account
More of MedaSync with a free account
  • ·Watch MedaSync: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

MedaSync funding history

2 rounds
DateRoundRaisedPost-money
Feb 2024Seed Round$1.6M▮
Jul 2018Debt$550K▮
Unlock post-money valuations

Membership and data by Private Market View

MedaSync valuation

MedaSync was valued at $11.2 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has MedaSync raised?

MedaSync has raised $3.6 million in total; 2 of its rounds are on record. The largest on record was a $550,000 debt round in Jul 2018; the most recent was a $1.6 million seed round in Feb 2024.

MedaSync has filed 2 Form Ds with the SEC since 2018, most recently in Aug 2025 ($1.6 million sold to 18 investors).

How MedaSync's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For MedaSync, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about MedaSync

What is MedaSync worth?
MedaSync is valued at $11.2M as of Oct 2026. Valued at $11.2M at its later-stage round, Aug 2025. Nothing has traded since.
How much has MedaSync raised?
MedaSync has raised $3.6M in total funding across 2 recorded rounds.
When did MedaSync last raise?
MedaSync last raised in Feb 2024 (Seed Round), raising $1.6M.